BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12905530)

  • 21. Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel.
    Ganguly A; Yang H; Cabral F
    Mol Cancer Ther; 2011 Jun; 10(6):929-37. PubMed ID: 21471284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
    Wiesen KM; Xia S; Yang CP; Horwitz SB
    Cancer Lett; 2007 Nov; 257(2):227-35. PubMed ID: 17869412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hook-related protein family and the characterization of hook-related protein 1.
    Simpson F; Martin S; Evans TM; Kerr M; James DE; Parton RG; Teasdale RD; Wicking C
    Traffic; 2005 Jun; 6(6):442-58. PubMed ID: 15882442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms.
    Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV
    Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin.
    Umezu T; Shibata K; Kajiyama H; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Gynecol Pathol; 2008 Apr; 27(2):207-12. PubMed ID: 18317222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H; Kearney CM; Pinney KG
    Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
    Gapud EJ; Bai R; Ghosh AK; Hamel E
    Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel resistance in cells with reduced beta-tubulin.
    Wang Y; Cabral F
    Biochim Biophys Acta; 2005 Jun; 1744(2):245-55. PubMed ID: 15950754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemid.
    Yin S; Cabral F; Veeraraghavan S
    Mol Cancer Ther; 2007 Oct; 6(10):2798-806. PubMed ID: 17938271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
    Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE
    Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.
    Gonzalez-Garay ML; Chang L; Blade K; Menick DR; Cabral F
    J Biol Chem; 1999 Aug; 274(34):23875-82. PubMed ID: 10446152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific microtubule functions in Drosophila spermatogenesis require the beta 2-tubulin isotype-specific carboxy terminus.
    Fackenthal JD; Turner FR; Raff EC
    Dev Biol; 1993 Jul; 158(1):213-27. PubMed ID: 8330671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity.
    Dráberová E; Del Valle L; Gordon J; Marková V; Smejkalová B; Bertrand L; de Chadarévian JP; Agamanolis DP; Legido A; Khalili K; Dráber P; Katsetos CD
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):341-54. PubMed ID: 18379434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site.
    Sève P; Reiman T; Isaac S; Trillet-Lenoir V; Lafanéchère L; Sawyer M; Dumontet C
    Anticancer Res; 2008; 28(2B):1161-7. PubMed ID: 18505052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cold-adapted beta-tubulins confer cold-tolerance to human cellular microtubules.
    Modig C; Wallin M; Olsson PE
    Biochem Biophys Res Commun; 2000 Mar; 269(3):787-91. PubMed ID: 10720493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical genetic analysis of indanocine resistance in human leukemia.
    Hua XH; Genini D; Gussio R; Tawatao R; Shih H; Kipps TJ; Carson DA; Leoni LM
    Cancer Res; 2001 Oct; 61(19):7248-54. PubMed ID: 11585762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
    Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
    Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
    Gökmen-Polar Y; Escuin D; Walls CD; Soule SE; Wang Y; Sanders KL; Lavallee TM; Wang M; Guenther BD; Giannakakou P; Sledge GW
    Cancer Res; 2005 Oct; 65(20):9406-14. PubMed ID: 16230404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
    Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR
    Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.